Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pronostics in Austria and Germany agreement with Medipan

This article was originally published in Clinica

Executive Summary

Multiplexed diagnostics manufacturer Pronostics has signed up German medical device distributor Medipan, as the exclusive marketer of its UltraPlex assays in Germany and Austria. The deal will see Berlin-based Medipan distribute Pronostics' UltraPlex ANA, Coeliac and Thyroid autoimmune disease biomarker assays to hospitals and private laboratories throughout the two countries. According to Cambridge, UK-based Pronostics, the deal could initially generate around E2m ($3.2m) in revenue annually, however, no other financial details were disclosed. Pronostics claims that in 2005, the worldwide market for autoimmune tests was in the region of $250m and is expected to grow to around $410m by 2010. The UltraPlex ANA, the firm's lead technology, enables 11 tests to be carried out at once using a microscopic bar-coding system. This helps reduce time and costs, when compared to existing serial testing methods, such as Hep-2 screens and ELISA tests.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046497

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel